PI
ABCL icon

PFG Investments’s AbCellera Biologics ABCL Stock Holding History

PFG Investments’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-12,610
Closed -$63.4K – 1151
2025
Q3 		$63.4K Buy
12,610
+110
+0.9% +$485 ﹤0.01% 1075
2025
Q2 		$42.9K Hold
12,500
– – ﹤0.01% 1015
2025
Q1 		$27.9K Sell
12,500
-1,500
-11% -$4.3K ﹤0.01% 991
2024
Q4 		$41K Hold
14,000
– – ﹤0.01% 988
2024
Q3 		$36.4K Sell
14,000
-1,100
-7% -$3.05K ﹤0.01% 981
2024
Q2 		$44.7K Sell
15,100
-1,500
-9% -$5.68K ﹤0.01% 898
2024
Q1 		$75.2K Buy
+16,600
New +$84.7K ﹤0.01% 981

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return